About Us

HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies to fight cancer and chronic infectious disease.

We are pioneering a proprietary arenavirus platform technology to develop therapies that are designed to reprogram the body’s immune system. We engineer arenaviruses (or vectors) to induce robust and durable antigen-specific T cell responses and pathogen-neutralizing antibodies to fight cancer and infectious diseases. We are the first to engineer arenaviruses for therapeutic purposes and our technology has elicited T cell response levels not achieved by other published immunotherapy approaches.

As a global company, we are advancing our diverse pipeline across a number of diseases with considerable unmet need and are partnering with key organizations to further develop potential therapeutic options. To learn more about our pipeline, see here.